Jubilant Ingrevia Share Price

Jubilant Ingrevia Limited, formerly known as Jubilant LSI Limited was incorporated as a Public Limited Company on October 23, 2019 in Uttar Pradesh. The name of the Company was subsequently changed from Jubilant LSI Limited to Jubilant Ingrevia Limited on October 16, 2020. The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. The Company is engaged in manufacturing and supply of speciality intermediates, nutrition health solutions and life science chemicals through five manufacturing facilities in India. The Company offer a range of products including straight Nutritional Ingredients like Vitamin B3, Picolinates to premix solutions for animal and human nutrition. The Life Science Chemicals and Speciality Chemicals segments provide complete backward integration giving competitive edge over competitors. The Company is the global largest producer of Niacinamide and amongst Global top two manufacturers of Vitamin B3 and Indias largest manufacturer of Vitamin B4. The Company is a Partner of Choice for more than 400 global customers. It has also embarked on the manufacturing of herbal range of products for animal feed under the brand Phytoshield. The Life Science Ingredients (LSI) business of Jubilant Pharmova Limited was demerged into the Company, (Jubilant Ingrevia Limited) through the Scheme of Amalgamation effective from February 1, 2021. Pursuant to Composite Scheme of Arrangement, 5 subsidiary companies of Jubilant Pharmova Limited namely, Jubilant Infrastructure Limited, Jubilant Life Sciences (USA) Inc., Jubilant Life Sciences International Pte. Limited, Jubilant Life Sciences (Shanghai) Limited and Jubilant Life Sciences NV became subsidiaries of the Company effective from the said date.During FY 202223, the Company acquired 37.98% of equity share capital of Mister Veg Foods Private Limited (MVFPL) effective March 16, 2023. It commissioned the 25,000 TPA New Acetic Anhydride Plant in Bharuch, Gujarat.The Company launched new products by introducing the foodgrade Choline Chloride and Choline Bitartrate in FY24. Further, a new agrochemical plant at SEZ Bharuch commissioned in FY 2024. The Phase II of Diketene Derivatives with the addition of 2000 TPA for multiple products was commissioned. A multipurpose Agro Actives Intermediate plant in Bharuch and a Diketene Derivatives plant in Gajraula commissioned in FY24.New plants commissioned for food and cosmeticgrade niacinamide/niacin facility and Diketene derivatives plants in FY 2025.The Company acquired 100% stake in Remidex Pharma Private Limited, making it a wholly owned subsidiary of the Company in March 2026. As a result, the Human Nutrition Business was scaled by expanding in the Vitamin and Mineral Premixes. Agro CDMO facility was commissioned in March 2026.

For the full year FY2026–2027, revenue reached ₹4428.6 crore and profit touched at ₹278.08 crore. As of Jun '26, Jubilant Ingrevia’s market capitalisation stood at ₹10,999.16 crores. Shareholding as of Jun '26 shows promoters holding 45.2%, with FIIs at 6.5%, DIIs at 25%, and public at 22.3%.